Research / AXIL / Fundamental state Inspectable configuration
State dimensions Filing 0001520138-26-000006 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
1.70% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.35% · OPTIONAL · VALID
Operating cash generation 75th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
11.49% · OPTIONAL · VALID
Revenue growth 20th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
5.20% · CORE · VALID
Inventory pressure 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
58.01% · OPTIONAL · VALID
Gross margin 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
68.06% · CORE · VALID
Operating margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
11.10% · CORE · VALID
SBC intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.14% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 36 states Self-history eligible
Aug 31, 2021 6/6 normalized Level 3 Nov 30, 2021 6/6 normalized Level 3 Feb 28, 2022 6/6 normalized Level 3 May 31, 2022 6/6 normalized Level 3 Aug 31, 2022 7/7 normalized Level 3 Nov 30, 2022 7/7 normalized Level 3 Feb 28, 2023 7/7 normalized Level 3 May 31, 2023 7/8 normalized Level 3 Aug 31, 2023 7/7 normalized Level 3 Nov 30, 2023 5/5 normalized Level 3 Feb 29, 2024 7/7 normalized Level 3 May 31, 2024 7/8 normalized Level 3 Aug 31, 2024 6/7 normalized Level 3 Nov 30, 2024 6/7 normalized Level 3 Feb 28, 2025 7/8 normalized Level 3 May 31, 2025 7/8 normalized Level 3 Aug 31, 2025 7/8 normalized Level 3 Nov 30, 2025 7/8 normalized Level 3 Feb 28, 2026 8/8 normalized Level 3 May 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 2.03%
Current 1.70%
Delta -0.33% Capex Intensity Increased
Previous 0.12%
Current 0.35%
Delta 0.23% Cash Generation Increased
Previous -10.78%
Current 11.49%
Delta 22.27% Growth Decreased
Previous 17.17%
Current 5.20%
Delta -11.97% Inventory Pressure Increased
Previous 56.73%
Current 58.01%
Delta 1.28% Margin Increased
Previous 67.60%
Current 68.06%
Delta 0.45% Profitability Increased
Previous 6.01%
Current 11.10%
Delta 5.10% Sbc Intensity Increased
Previous 2.91%
Current 4.14%
Delta 1.24% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.